Related Experiment Videos
Platelet-complement interactions in mesangial proliferative nephritis in the rat.
R J Johnson1, P Pritzl, H Iida
1Department of Medicine, University of Washington, Seattle.
The American Journal of Pathology
|February 1, 1991
Summary
Complement depletion significantly reduces mesangiolysis, cell proliferation, and leukocyte infiltration in anti-Thy 1 glomerulonephritis. This study reveals complement
Area of Science:
- Nephrology
- Immunology
- Pathology
Background:
- Complement activation is implicated in mesangiolysis and glomerular hypercellularity in anti-Thy 1 glomerulonephritis (GN).
- The precise mechanism of complement-mediated hypercellularity, whether through cell proliferation or leukocyte infiltration, requires elucidation.
- Recent findings suggest platelets contribute to glomerular cell proliferation in this model.
Purpose of the Study:
- To investigate the role of complement in mediating glomerular hypercellularity in anti-Thy 1 GN.
- To determine if complement depletion inhibits cell proliferation or leukocyte infiltration.
- To examine the involvement of glomerular platelet localization in complement-mediated cell proliferation.
Main Methods:
- Rats with anti-Thy 1 GN were depleted of complement using cobra venom factor (CVF).
- Mesangiolysis, cell proliferation (PCNA/cyclin staining), and leukocyte infiltration were assessed.
- Glomerular platelet uptake was quantified using 111In-labeled platelets in normal and CVF-treated rats.
Main Results:
- CVF treatment significantly reduced mesangiolysis, cell proliferation, and leukocyte infiltration compared to controls.
- Rats with anti-Thy 1 GN exhibited substantial glomerular platelet accumulation.
- Complement depletion profoundly inhibited glomerular platelet localization in anti-Thy 1 GN.
Conclusions:
- Complement plays a crucial role in mediating platelet localization in anti-Thy 1 GN.
- This complement-driven platelet localization may explain the observed neutrophil-independent glomerular hypercellularity.
- Complement depletion offers a potential therapeutic strategy by reducing key pathological processes in anti-Thy 1 GN.